Hereditary prostate cancerBRATT, O.BJU international (Papier). 2000, Vol 85, Num 5, pp 588-598, issn 1464-4096Article

The risk of malignant tumours in first-degree relatives of men with early onset prostate cancer : A population-based cohort studyBRATT, O; KRISTOFFERSSON, U; LUNDGREN, R et al.European journal of cancer (1990). 1997, Vol 33, Num 13, pp 2237-2240, issn 0959-8049Article

CHEK*1100delC is not an important high-risk gene in families with hereditary prostate cancer in southern SwedenWAGENIUS, M; BORG, A; JOHANSSON, L et al.Scandinavian journal of urology and nephrology. 2006, Vol 40, Num 1, pp 23-25, issn 0036-5599, 3 p.Article

Morbidity of pelvic lymphadenectomy, radical retropubic prostatectomy and external radiotherapy in patients with localised prostatic cancerBRATT, O; ELFVING, P; FLODGREN, P et al.Scandinavian journal of urology and nephrology. 1994, Vol 28, Num 3, pp 265-271, issn 0036-5599Article

Familial and hereditary prostate cancer in southern Sweden. A population-based case-control studyBRATT, O; KRISTOFFERSSON, U; LUNDGREN, R et al.European journal of cancer (1990). 1999, Vol 35, Num 2, pp 272-277, issn 0959-8049Article

Clinical course of early onset prostate cancer with special reference to family history as a prognostic factorBRATT, O; KRISTOFFERSSON, U; OLSSON, H et al.European urology. 1998, Vol 34, Num 1, pp 19-24, issn 0302-2838Article

Sons of men with prostate cancer : Their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testingBRATT, O; KRISTOFFERSSON, U; LUNDGREN, R et al.Urology (Ridgewood, NJ). 1997, Vol 50, Num 3, pp 360-365, issn 0090-4295Article

Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancerBRATT, O; HAGGMAN, M; AHLGREN, G et al.British journal of cancer. 2009, Vol 101, Num 8, pp 1233-1240, issn 0007-0920, 8 p.Article

Hereditary prostate cancer: Clinical characteristics and survivalBRATT, O; DAMBER, J.-E; EMANUELSSON, M et al.The Journal of urology. 2002, Vol 167, Num 6, pp 2423-2426, issn 0022-5347Article

CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer riskBRATT, O; BORG, A; KRISTOFFERSSON, U et al.British journal of cancer. 1999, Vol 81, Num 4, pp 672-676, issn 0007-0920Conference Paper

Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer : influence on prognosisBRATT, O; ANDERSON, H; BAK-JENSEN, E et al.Urology (Ridgewood, NJ). 1996, Vol 47, Num 2, pp 218-224, issn 0090-4295Article

Acupuncture fails to reduce but increases anaesthetic gas required to prevent movement in response to surgical incisionKVORNING, N; CHRISTIANSSON, C; BESKOW, A et al.Acta anaesthesiologica scandinavica. 2003, Vol 47, Num 7, pp 818-822, issn 0001-5172, 5 p.Article

Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancerBRATT, O; DAMBER, J.-E; EMANUELSSON, M et al.European journal of cancer (1990). 2000, Vol 36, Num 2, pp 235-241, issn 0959-8049Article